Digitale Bibliotheek
Sluiten Bladeren door artikelen uit een tijdschrift
 
Zoeken naar met titel:
ABCDEFGHIJKLMNOPQRSTUVWXYZ

     Tijdschrift beschrijving
       Alle jaargangen van het bijbehorende tijdschrift
         Alle afleveringen van het bijbehorende jaargang
                                       Alle artikelen van de bijbehorende aflevering
 
                             34 gevonden resultaten
nr titel auteur tijdschrift jaar jaarg. afl. pagina('s) type
1 Acceptable Safety of Bevacizumab Therapy in Patients with Brain Metastases as a Result of Non—Small-Cell Lung Cancer Akerley, Wallace
 2008
 9 Supplement 2 p. 306-
1 p.
 artikel
2 An Interdisciplinary Care Approach for Integration of Palliative Care in Lung Cancer Borneman, Tami
 2008
 9 Supplement 2 p. 352-360
9 p.
 artikel
3 A Phase II Study of Erlotinib as a First-Line Therapy for Patients with Non—Small-Cell Lung Cancer with Favorable Clinical Predictors Lee, Dae Ho
 2008
 9 Supplement 2 p. 297-
1 p.
 artikel
4 A Randomized Phase II Trial of Oral Topotecan Versus Docetaxel in the Second-Line Treatment of Non–Small-Cell Lung Cancer Jones, Suzanne
 2008
 9 Supplement 2 p. 154-159
6 p.
 artikel
5 Assessment of Guilt and Shame in Patients with Non–Small-Cell Lung Cancer Compared with Patients with Breast and Prostate Cancer LoConte, Noelle K.
 2008
 9 Supplement 2 p. 171-178
8 p.
 artikel
6 Brain Metastases in N2-Positive Non–Small-Cell Lung Cancer: Implications for Prophylactic Cranial Irradiation Bansal, Mohit
 2008
 9 Supplement 2 p. 227-229
3 p.
 artikel
7 Bronchioloalveolar Carcinoma: The Case for Two Diseases Garfield, David H.
 2008
 9 Supplement 2 p. 24-29
6 p.
 artikel
8 Chemotherapy for Brain Metastases in Small-Cell Lung Cancer Chen, Gigi
 2008
 9 Supplement 2 p. 35-38
4 p.
 artikel
9 Current State of Vaccine Therapies in Non–Small-Cell Lung Cancer Romero, Pedro
 2008
 9 Supplement 2 p. S28-S36
9 p.
 artikel
10 Emerging Safety Data for Bevacizumab in Advanced Non–Small-Cell Lung Cancer Hirsh, Vera
 2008
 9 Supplement 2 p. S62-S70
9 p.
 artikel
11 Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors as a First-Line Therapy for Never-Smokers with Adenocarcinoma of the Lung and Asymptomatic Synchronous Brain Metastasis Lee, Dae Ho
 2008
 9 Supplement 2 p. 296-
1 p.
 artikel
12 Esophageal and Laryngeal Cancer Incidentally Found on [18F]Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography During the Staging Workup for Lung Cancer Jeon, Se Yong
 2008
 9 Supplement 2 p. 230-231
2 p.
 artikel
13 Exosomal microRNA: A Diagnostic Marker for Lung Cancer Kloecker, Goetz H.
 2008
 9 Supplement 2 p. 295-
1 p.
 artikel
14 Fractionated Stereotactic Body Radiation Therapy in the Treatment of Primary, Recurrent, and Metastatic Lung Tumors: The Role of Positron Emission Tomography/Computed Tomography–Based Treatment Planning Coon, Devin
 2008
 9 Supplement 2 p. 217-221
5 p.
 artikel
15 Induction Chemotherapy with Cisplatin, Vinorelbine, and Mitomycin-C Followed by Surgery for Patients with Pathologic N2 Non–Small-Cell Lung Cancer Akamine, Shinji
 2008
 9 Supplement 2 p. 44-50
7 p.
 artikel
16 Metronomic Chemotherapy in Patients with Advanced Non—Small-Cell Lung Cancer Associated with Long-Term Survival Chen, Nick
 2008
 9 Supplement 2 p. 290-
1 p.
 artikel
17 New Targeted Therapies and Small-Cell Lung Cancer Rossi, Antonio
 2008
 9 Supplement 2 p. 271-279
9 p.
 artikel
18 New Treatment Strategies in Patients with Advanced Non–Small-Cell Lung Cancer and Performance Status 2 Rodriguez, Estelamari
 2008
 9 Supplement 2 p. 326-330
5 p.
 artikel
19 Ongoing Trials with Bevacizumab and Other Antiangiogenic Agents in Lung Cancer Dowlati, Afshin
 2008
 9 Supplement 2 p. S71-S75
5 p.
 artikel
20 Optimizing the Dose and Schedule of Anti–Vascular Endothelial Growth Factor Antibodies in Non–Small-Cell Lung Cancer Klamerus, Justin F.
 2008
 9 Supplement 2 p. S51-S56
6 p.
 artikel
21 Pharmacogenomic Approaches to Individualizing Chemotherapy for Non–Small-Cell Lung Cancer: Current Status and New Directions Gautschi, Oliver
 2008
 9 Supplement 2 p. S129-S138
10 p.
 artikel
22 Population Characteristics and Prognostic Factors in Metastatic Non–Small-Cell Lung Cancer: A Fox Chase Cancer Center Retrospective Paralkar, Vikram R.
 2008
 9 Supplement 2 p. 116-121
6 p.
 artikel
23 Preliminary Treatment Patterns and Safety Outcomes for Non—Small-Cell Lung Cancer from ARIES, a Bevacizumab Treatment Observational Cohort Study Spigel, David
 2008
 9 Supplement 2 p. 302-
1 p.
 artikel
24 Restrictive Eligibility Limits Access to Newer Therapies in Non–Small-Cell Lung Cancer: The Implications of Eastern Cooperative Oncology Group 4599 Somer, Robert A.
 2008
 9 Supplement 2 p. 102-105
4 p.
 artikel
25 Selected Clinical Trials in Lung Cancer Langer, Corey J.
 2008
 9 Supplement 2 p. 61-
1 p.
 artikel
26 Serum Endothelial Monocyte-Activating Polypeptide–II: A Novel Biomarker in Patients with Non–Small-Cell Lung Cancer Sen, Elif
 2008
 9 Supplement 2 p. 166-170
5 p.
 artikel
27 Sunitinib plus Erlotinib for the Treatment of Metastatic Non—Small-Cell Lung Cancer: A Novel VEGFR—EGFR Co-Inhibition Treatment Strategy Scagliotti, Giorgio V.
 2008
 9 Supplement 2 p. 300-
1 p.
 artikel
28 Symptom Concerns and Use of Supportive Services in Patients with Lung Cancer Borneman, Tami
 2008
 9 Supplement 2 p. 288-
1 p.
 artikel
29 Targeting Wnt-2 in Mesothelioma and Lung Cancer Bravo, Dawn T.
 2008
 9 Supplement 2 p. 289-
1 p.
 artikel
30 The Clinical Development of Vandetanib: Updates on Ongoing Phase III Clinical Trials in Advanced Non—Small-Cell Lung Cancer Heymach, John
 2008
 9 Supplement 2 p. 292-
1 p.
 artikel
31 Thrombin-Activatable Fibrinolysis Inhibitor Levels in Patients with Non–Small-Cell Lung Cancer Koldas, Macit
 2008
 9 Supplement 2 p. 112-115
4 p.
 artikel
32 Tracheoesophageal Fistula Development and Concurrent Chemoradiation and Bevacizumab in Non—Small-Cell Lung Cancer Spigel, David R.
 2008
 9 Supplement 2 p. 303-
1 p.
 artikel
33 Treatment of Patients with Advanced Non–Small-Cell Lung Cancer with Performance Status of 2: An Unsolved Issue Gridelli, Cesare
 2008
 9 Supplement 2 p. 324-325
2 p.
 artikel
34 Weekly Paclitaxel in Elderly Patients (Aged ≥ 70 Years) with Advanced Non–Small-Cell Lung Cancer: An Alternative Choice? Results of a Phase II Study Rossi, David
 2008
 9 Supplement 2 p. 280-284
5 p.
 artikel
                             34 gevonden resultaten
 
 Koninklijke Bibliotheek - Nationale Bibliotheek van Nederland